Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
ABIM, Acacia, accelerated, accessible, Accredo, adherence, Andre, announced, announcing, annum, appraisal, ascribe, assembled, Attending, auditor, avoided, avoiding, Belgium, Bellevue, bioequivalence, bioequivalency, Biopharma, branded, breast, broader, Brunswick, BS, buying, caption, carrier, CEO, cGMP, choose, Christopher, Cincinnati, Clement, climate, complement, condensed, conference, Conrad, consequential, consumption, context, convenience, County, cycle, daily, Dealer, Diplomate, disclosed, double, Draximage, EITF, electronically, Eleven, Endocrinology, Epicyte, erosion, exact, exempt, exhausted, exit, external, false, familiarity, fiduciary, filer, FIN, forecast, fraud, freight, Gamble, Gouverneur, Groenewegen, guarantor, guaranty, guidance, HAA, hand, handle, heavier, heavily, heavy, history, Horowitz, hypersensitivity, improve, inception, inclusion, Incremental, Indian, Indirect, injure, interpretation, intrinsic, introductory, Iraq, irrevocable, Jr, KPMG, leave, Lehigh, lengthy, licensure, likelihood, Luxembourg, malignant, mandate, master, MCA, Mercy, Metabolilsm, Middlesex, Millet, minimal, misleading, modification, monetary, NARC, Nelson, neonatal, neurobiology, nominal, observed, occasion, Ohio, passed, pattern, pertaining, Physician, PhytoCeutica, Pior, plaintiff, popular, Portugal, pound, pressure, Procter, profile, prominent, prominently, proof, prospective, prospectively, protocol, question, radioactive, reaudit, recall, recessionary, recourse, recruiting, refine, refinement, release, reliably, renegotiate, renegotiated, reputation, resell, resignation, resigned, resolution, resumption, revision, role, Rosemont, route, Sabex, Sandoz, Schein, SCV, SEC, shareholder, simple, site, situation, Soltamox, Solvay, source, sourced, Spain, Specialist, specialty, SPRL, stable, staffing, statistical, sterling, storage, strong, supervision, sustain, tamoxifen, Task, testostrone, Thornton, transcript, trend, Tuvia, Ultrecht, unconditional, understand, undiscounted, unexpected, unfair, unforeseen, unlicensed, Unlimited, unspecified, untrue, upward, vesting, Vietnam, virtually, visit, voluntary, warehousing, website, whichever, Whitney, withhold, wrongdoing, Zebulun
Removed:
Administrator, agricultural, Air, Allergan, Atomic, Avigdor, bacteria, bacterially, Barton, Bethesda, Biochemical, biochemistry, Brown, Centocor, Chiron, Ciba, clause, Clean, collection, compensate, Conservation, CSL, declaration, designation, devalued, direction, discontinue, dislodgement, disputed, Donald, enable, Energy, Engineer, enhancement, Enzon, enzymatically, expire, finalizing, Fischer, Fishbein, Gaucher, glucocerebrosidase, greatly, headed, hereinafter, Hungary, Indiana, instrumental, internationally, invented, invention, investigation, Iselin, John, Korea, label, Lawrence, Leah, legislative, Levanon, lipid, Maryland, Meir, nearby, neurologist, Norman, Occupational, Olsten, operational, precluding, promoted, proportional, puberty, Rachel, reconstruction, region, renowned, representative, Resource, Ronald, Russia, Simko, somatropin, sterile, Stroke, suitable, toxic, toxicology, tradename, Treasury, twelve, undergraduate, unit, unpatentable, Virology, virtue, Vision, Volcani, Weizmann, Wellcome, Zelig, Zurich, Zvi
Filing tables
Filing exhibits
SVNT similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Certified Public Accountants
We have issued our report dated February 14, 2003, accompanying the consolidated financial statements included in the Annual Report of Bio-Technology General Corp. on Form 10-K for the year ended December 31, 2002. We hereby consent to the incorporation by reference of said report in the registration statement Nos. 33-51202, 33-83904, 33-69870, 33-41591, 33-41593, 333-36121, 333-33073, 333-33075, 333-64541, and 333-87344 on Form S-8 of Bio-Technology General Corp.
| /s/ GRANT THORNTON LLP |
|
|
|
| ||
New York, New York |
| ||
March 28, 2003 |
|